One study has revealed that among patients with RCC, those who have bone metastases have higher serum CCL20 levels than those who do not have bone metastases and that the CCL20-CCR6 axis perhaps be involved in RCC bone metastases [74]. Here, CCL20 is linked to renal cell carcinoma.